Table 1.
Breast invasive ductal carcinoma patient’s clinicopathological features
|
| |||
|---|---|---|---|
| Variable | n (%) | ||
|
| |||
| Age (Y) | |||
| <47 | 44 (48.88) | ||
| ≥47 | 46 (51.11) | ||
| T stage | |||
| T1 ≤2 | 38 (42.22) | ||
| T2 | }>2 | 15 (16.67) | |
| T3 | 19 (21.11) | ||
| T4 | 18 (20) | ||
| Lymph node involvement | |||
| Positive | 54 (60) | ||
| Negative | 36 (40) | ||
| Metastasis status | |||
| Metastatic | 30 (33.33) | ||
| Non-metastatic | 60 (66.67) | ||
| Clinical TNM staging | |||
| I | 30 (33.33) | ||
| II and III | 30 (33.33) | ||
| IV | 30 (33.33) | ||
|
| |||
TNM; Tumor, nodes, and metastases.